Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Kawasaki disease (KD) is an acute febrile vasculitis that occurs mostly in children younger than five years. KD involves multiple intricately connected inflammatory reactions activated by a cytokine cascade. Despite therapeutic advances, coronary artery damage may develop in some patients, who will be at risk of clinical cardiovascular events and even sudden death. The etiology of KD remains unclear; however, it may involve both genetic and environmental factors leading to aberrant inflammatory responses. Given the young age of onset, prenatal or perinatal exposure may be etiologically relevant. Multisystem inflammatory syndrome in children, a post-infectious hyper-inflammatory disorder associated with severe acute respiratory syndrome coronavirus 2, has features that overlap with those of KD. Available evidence indicates that vascular endothelial dysfunction is a critical step in the sequence of events leading to the development of cardiovascular lesions in KD. Oxidative stress and the dysregulation of the nitric oxide (NO) system contribute to the pathogenesis of inflammatory responses related to this disease. This review provides current evidence and concepts highlighting the adverse effects of oxidative injury and NO system derangements on the initiation and progression of KD and potential therapeutic strategies for cardiovascular pathologies in affected children.
Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease.
Paolini L, Guida F, Calvaruso A, Andreozzi L, Pierantoni L, Lanari M Int J Mol Sci. 2025; 25(24.
PMID: 39769085 PMC: 11676170. DOI: 10.3390/ijms252413322.
A nomogram prediction of coronary artery dilation in Kawasaki diseases based on mtDNA copy number.
Peng M, Yue P, Zhang Y, Li H, Hua Y, Li Y Front Immunol. 2024; 15:1448558.
PMID: 39206185 PMC: 11349549. DOI: 10.3389/fimmu.2024.1448558.
Tsuge M, Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K Int J Mol Sci. 2024; 25(15).
PMID: 39125944 PMC: 11313210. DOI: 10.3390/ijms25158370.
Hydrogen Gas Inhalation Treatment for Coronary Artery Lesions in a Kawasaki Disease Mouse Model.
Shih W, Yeh T, Chen K, Leu S, Liu S, Huang Y Life (Basel). 2024; 14(7).
PMID: 39063551 PMC: 11277616. DOI: 10.3390/life14070796.
Ricke D, Smith N Life (Basel). 2024; 14(3).
PMID: 38541678 PMC: 10971466. DOI: 10.3390/life14030353.